Maria Fleseriu, MD
@mariafleseriu.bsky.social
#EndoSky #MedSky Neuroendocrinologist, Professor, Medicine & Neurosurgery, Director Pituitary Center, Oregon Health &Science University, Portland, Oregon, USA, Board of Directors The Endocrine Soc , Past President Pituitary Soc; Posts not medical advice
Reposted by Maria Fleseriu, MD
Read our December Issue, featuring familial hypercholesterolaemia, chronic kidney disease, type 2 diabetes, cyclic Cushing’s syndrome, primary aldosteronism, type 1 diabetes, menopause, obesity, iodine deficiency, & much more tinyurl.com/mwfu4c6m
#MedSky #EndoSky #RenalSky #CardioSky
#MedSky #EndoSky #RenalSky #CardioSky
November 11, 2025 at 11:33 PM
Read our December Issue, featuring familial hypercholesterolaemia, chronic kidney disease, type 2 diabetes, cyclic Cushing’s syndrome, primary aldosteronism, type 1 diabetes, menopause, obesity, iodine deficiency, & much more tinyurl.com/mwfu4c6m
#MedSky #EndoSky #RenalSky #CardioSky
#MedSky #EndoSky #RenalSky #CardioSky
Reposted by Maria Fleseriu, MD
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan...
cyclic #Cushing's syndrome (#cCS)
#MedSky #EndoSky
cyclic #Cushing's syndrome (#cCS)
#MedSky #EndoSky
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with
high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor
outcomes. Ectopic cCS showed the mo...
thelancet.com
November 10, 2025 at 7:22 PM
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan...
cyclic #Cushing's syndrome (#cCS)
#MedSky #EndoSky
cyclic #Cushing's syndrome (#cCS)
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
#Hyperprolactinaemia can result from dopamine antagonist drug effects and reduced prolactin clearance with liver or kidney disease with loss of feedback regulation thelancet.com/journals/lan...
#prolactinoma #pituitary #adenoma
#MedSky #EndoSky
#prolactinoma #pituitary #adenoma
#MedSky #EndoSky
October 10, 2025 at 3:56 PM
#Hyperprolactinaemia can result from dopamine antagonist drug effects and reduced prolactin clearance with liver or kidney disease with loss of feedback regulation thelancet.com/journals/lan...
#prolactinoma #pituitary #adenoma
#MedSky #EndoSky
#prolactinoma #pituitary #adenoma
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
#Prolactinomas are the most common pathological cause of #hyperprolactinaemia and represent approximately half of #pituitary #adenomas thelancet.com/journals/lan...
#pituitary
#MedSky #EndoSky
#pituitary
#MedSky #EndoSky
October 19, 2025 at 9:33 AM
#Prolactinomas are the most common pathological cause of #hyperprolactinaemia and represent approximately half of #pituitary #adenomas thelancet.com/journals/lan...
#pituitary
#MedSky #EndoSky
#pituitary
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
New—Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan...
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with
high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor
outcomes. Ectopic cCS showed the mo...
thelancet.com
October 24, 2025 at 6:12 AM
New—Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan...
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous #adrenal #insufficiency, inappropriate surgeries, and poor outcomes www.thelancet.com/journals/lan...
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with
high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor
outcomes. Ectopic cCS showed the mo...
www.thelancet.com
October 25, 2025 at 9:16 AM
Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous #adrenal #insufficiency, inappropriate surgeries, and poor outcomes www.thelancet.com/journals/lan...
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
cyclic #Cushing's syndrome #cCS
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
Prolactinomas are the most common pathological cause of hyperprolactinaemia and represent approximately half of pituitary adenomas thelancet.com/journals/lan...
#prolactinomas #hyperprolactinaemia #pituitary
#MedSky #EndoSky
#prolactinomas #hyperprolactinaemia #pituitary
#MedSky #EndoSky
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management
Hyperprolactinaemia can result from physiological causes, pharmacological agents,
or pathological conditions such as prolactin-secreting pituitary adenomas and other
pituitary stalk-compressing masses...
thelancet.com
November 1, 2025 at 2:33 PM
Prolactinomas are the most common pathological cause of hyperprolactinaemia and represent approximately half of pituitary adenomas thelancet.com/journals/lan...
#prolactinomas #hyperprolactinaemia #pituitary
#MedSky #EndoSky
#prolactinomas #hyperprolactinaemia #pituitary
#MedSky #EndoSky
Reposted by Maria Fleseriu, MD
From our November issue: a Consensus Statement on acromegaly therapeutic outcomes from Andrea Giustina and colleagues go.nature.com/3KJIQa8 #EndoSky #MedSky
October 10, 2025 at 3:15 PM
From our November issue: a Consensus Statement on acromegaly therapeutic outcomes from Andrea Giustina and colleagues go.nature.com/3KJIQa8 #EndoSky #MedSky
Reposted by Maria Fleseriu, MD
#Hyperprolactinaemia can result from physiological causes, pharmacological agents, or pathological conditions such as prolactin-secreting #pituitary #adenomas and other pituitary stalk-compressing masses www.thelancet.com/journals/lan...
#prolactinomas
#prolactinomas
September 20, 2025 at 9:53 AM
#Hyperprolactinaemia can result from physiological causes, pharmacological agents, or pathological conditions such as prolactin-secreting #pituitary #adenomas and other pituitary stalk-compressing masses www.thelancet.com/journals/lan...
#prolactinomas
#prolactinomas
Reposted by Maria Fleseriu, MD
Our October Issue is now online, featuring prediabetes remission, obesity, type 1 diabetes, biased GLP-1 receptor agonists, type 2 diabetes, prolactin-secreting adenomas, malnutrition-related diabetes, food system, NCDs & much more www.thelancet.com/journals/lan...
#MedSky #EndoSky #OncSky
#MedSky #EndoSky #OncSky
September 9, 2025 at 10:35 PM
Our October Issue is now online, featuring prediabetes remission, obesity, type 1 diabetes, biased GLP-1 receptor agonists, type 2 diabetes, prolactin-secreting adenomas, malnutrition-related diabetes, food system, NCDs & much more www.thelancet.com/journals/lan...
#MedSky #EndoSky #OncSky
#MedSky #EndoSky #OncSky
Reposted by Maria Fleseriu, MD
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
#endocrinology @TheEndoSociety
ENDO 2026 Session Submissions
ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...
bit.ly
August 28, 2025 at 4:35 PM
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
#endocrinology @TheEndoSociety
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management - The Lancet Diabetes & Endocrinology
Personalized Share Link free download
authors.elsevier.com/a/1lfru_oLbg...
Personalized Share Link free download
authors.elsevier.com/a/1lfru_oLbg...
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management
Hyperprolactinaemia can result from physiological causes, pharmacological agents,
or pathological conditions such as prolactin-secreting pituitary adenomas and other
pituitary stalk-compressing masses...
www.thelancet.com
August 27, 2025 at 2:11 AM
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management - The Lancet Diabetes & Endocrinology
Personalized Share Link free download
authors.elsevier.com/a/1lfru_oLbg...
Personalized Share Link free download
authors.elsevier.com/a/1lfru_oLbg...
Reposted by Maria Fleseriu, MD
In this Review, Daniela Esposito et al discuss the pathophysiology, clinical challenges and management of #diabetes mellitus in patients with #acromegaly (£) bit.ly/3HkGAVp #EndoSky #MedSky
August 13, 2025 at 9:33 AM
In this Review, Daniela Esposito et al discuss the pathophysiology, clinical challenges and management of #diabetes mellitus in patients with #acromegaly (£) bit.ly/3HkGAVp #EndoSky #MedSky
Reposted by Maria Fleseriu, MD
New content online: Consensus on acromegaly therapeutic outcomes: an update
Consensus on acromegaly therapeutic outcomes: an update
Nature Reviews Endocrinology, Published online: 13 August 2025; doi:10.1038/s41574-025-01148-2In this Consensus Statement, an international group of experts provide updated recommendations on the treatment of acromegaly, including discussion of treatment outcomes.
www.nature.com
August 13, 2025 at 3:02 PM
New content online: Consensus on acromegaly therapeutic outcomes: an update
Reposted by Maria Fleseriu, MD
#ENDO2025 - enjoyed scientific sessions reconnecting w/ friends and colleagues. A perfect mix of science & fun! @endocrinesociety.bsky.social @lmfendo.bsky.social @garydouglashammer.bsky.social @jeromebertherat.bsky.social @cronchi.bsky.social @mariafleseriu.bsky.social @bferrazdsouza.bsky.social
July 16, 2025 at 5:52 AM
#ENDO2025 - enjoyed scientific sessions reconnecting w/ friends and colleagues. A perfect mix of science & fun! @endocrinesociety.bsky.social @lmfendo.bsky.social @garydouglashammer.bsky.social @jeromebertherat.bsky.social @cronchi.bsky.social @mariafleseriu.bsky.social @bferrazdsouza.bsky.social
Reposted by Maria Fleseriu, MD
Join us for a @endocrinesociety.bsky.social and Pituitary Society session with Dr @mariafleseriu.bsky.social and Dr Ken Ho.
I’ll present our new sc multiomics results identifying gene regulatory circuits differentiating NFPA cells and control gonadotropes.
@endocrinenews.bsky.social
I’ll present our new sc multiomics results identifying gene regulatory circuits differentiating NFPA cells and control gonadotropes.
@endocrinenews.bsky.social
July 14, 2025 at 3:13 PM
Join us for a @endocrinesociety.bsky.social and Pituitary Society session with Dr @mariafleseriu.bsky.social and Dr Ken Ho.
I’ll present our new sc multiomics results identifying gene regulatory circuits differentiating NFPA cells and control gonadotropes.
@endocrinenews.bsky.social
I’ll present our new sc multiomics results identifying gene regulatory circuits differentiating NFPA cells and control gonadotropes.
@endocrinenews.bsky.social
Reposted by Maria Fleseriu, MD
Great & friendly international exchanges on pituitary diseases at the 19th International Pituitary Congress in San Francisco.
👏👏 @mariafleseriu.bsky.social
👏Kristina Isand for presenting the European perspective on #Cushing & venous thrombosis 👍
👏👏 @mariafleseriu.bsky.social
👏Kristina Isand for presenting the European perspective on #Cushing & venous thrombosis 👍
July 11, 2025 at 4:44 PM
Great & friendly international exchanges on pituitary diseases at the 19th International Pituitary Congress in San Francisco.
👏👏 @mariafleseriu.bsky.social
👏Kristina Isand for presenting the European perspective on #Cushing & venous thrombosis 👍
👏👏 @mariafleseriu.bsky.social
👏Kristina Isand for presenting the European perspective on #Cushing & venous thrombosis 👍
Reposted by Maria Fleseriu, MD
I’m here! #ENDO2025
Board meeting tomorrow and #ECF2025 Friday. One of my favorite events is the early career forum by the @endocrinesociety.bsky.social
Can’t wait to meet the trainees and often first timers to ENDO.
Board meeting tomorrow and #ECF2025 Friday. One of my favorite events is the early career forum by the @endocrinesociety.bsky.social
Can’t wait to meet the trainees and often first timers to ENDO.
July 10, 2025 at 4:34 AM
I’m here! #ENDO2025
Board meeting tomorrow and #ECF2025 Friday. One of my favorite events is the early career forum by the @endocrinesociety.bsky.social
Can’t wait to meet the trainees and often first timers to ENDO.
Board meeting tomorrow and #ECF2025 Friday. One of my favorite events is the early career forum by the @endocrinesociety.bsky.social
Can’t wait to meet the trainees and often first timers to ENDO.
Reposted by Maria Fleseriu, MD
SF bound ✈️!
Looking forward to meeting colleagues and collaborators and learning about all the science at #ENDO2025 and the Pituitary Society meetings.
@endocrinesociety.bsky.social
Looking forward to meeting colleagues and collaborators and learning about all the science at #ENDO2025 and the Pituitary Society meetings.
@endocrinesociety.bsky.social
Endocrine Society (@endocrinesociety.bsky.social)
We unite, lead, and grow the global endocrine community to accelerate scientific breakthroughs and improve health worldwide.
endocrine.org
endocrinesociety.bsky.social
July 9, 2025 at 1:13 PM
SF bound ✈️!
Looking forward to meeting colleagues and collaborators and learning about all the science at #ENDO2025 and the Pituitary Society meetings.
@endocrinesociety.bsky.social
Looking forward to meeting colleagues and collaborators and learning about all the science at #ENDO2025 and the Pituitary Society meetings.
@endocrinesociety.bsky.social
Happy to share our recent #consensus #guideline on how to multidisciplinary manage #pituitary #incidentalomas; good news on data to recommend less frequent #imaging for many microadenomas , but also smaller macroadenomas. @pituitarysociety.bsky.social @ohsubrain.bsky.social @ohsunews.bsky.social
June 24, 2025 at 3:29 PM
Happy to share our recent #consensus #guideline on how to multidisciplinary manage #pituitary #incidentalomas; good news on data to recommend less frequent #imaging for many microadenomas , but also smaller macroadenomas. @pituitarysociety.bsky.social @ohsubrain.bsky.social @ohsunews.bsky.social
Reposted by Maria Fleseriu, MD
New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature Reviews Endocrinology, Published online: 24 June 2025; doi:10.1038/s41574-025-01134-8This international Consensus Statement provides guidelines on the management of pituitary incidentalomas.
www.nature.com
June 24, 2025 at 8:03 AM
New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Reposted by Maria Fleseriu, MD
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
The #IMPROCUSH-5 meeting in Munich was a great occasion to discuss #Cushing and see "adrenal" friends @mariafleseriu.bsky.social @fbeuschlein.bsky.social 🤳👇👇
👏👏 Martin Reincke for this successfull 2025 edition
👏👏 Martin Reincke for this successfull 2025 edition
June 24, 2025 at 12:40 PM
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
The #IMPROCUSH-5 meeting in Munich was a great occasion to discuss #Cushing and see "adrenal" friends @mariafleseriu.bsky.social @fbeuschlein.bsky.social 🤳👇👇
👏👏 Martin Reincke for this successfull 2025 edition
👏👏 Martin Reincke for this successfull 2025 edition
June 24, 2025 at 12:40 PM
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
Reposted by Maria Fleseriu, MD
New @eclinicalmed.bsky.social:
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey www.thelancet.com/journals/ecl...
#PCOS
#OpenAccess
#MedSky #EndoSky #WomensHealthSky
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey www.thelancet.com/journals/ecl...
#PCOS
#OpenAccess
#MedSky #EndoSky #WomensHealthSky
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey
Widespread international engagement in 2015 showed major knowledge gaps on broad PCOS
features, with follow-up in 2023 showing significant improvement after two international
guidelines, widespread di...
www.thelancet.com
May 29, 2025 at 5:09 PM
New @eclinicalmed.bsky.social:
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey www.thelancet.com/journals/ecl...
#PCOS
#OpenAccess
#MedSky #EndoSky #WomensHealthSky
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey www.thelancet.com/journals/ecl...
#PCOS
#OpenAccess
#MedSky #EndoSky #WomensHealthSky
Reposted by Maria Fleseriu, MD
Mild autonomous cortisol secretion (MACS) associated with #unilateral #adrenal #incidentalomas is responsible for secondary #hypertension that can be safely improved by minimally-invasive #adrenalectomy www.thelancet.com/journals/lan...
#MedSky #EndoSky #OncSky #CardioSky
#MedSky #EndoSky #OncSky #CardioSky
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomis...
MACS associated with unilateral adrenal incidentalomas is responsible for secondary
hypertension that can be safely improved by minimally-invasive adrenalectomy.
www.thelancet.com
May 12, 2025 at 10:43 PM
Mild autonomous cortisol secretion (MACS) associated with #unilateral #adrenal #incidentalomas is responsible for secondary #hypertension that can be safely improved by minimally-invasive #adrenalectomy www.thelancet.com/journals/lan...
#MedSky #EndoSky #OncSky #CardioSky
#MedSky #EndoSky #OncSky #CardioSky